flavone acetic acid has been researched along with Malignant Melanoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 11 (91.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conlon, KC; Fenton, RG; Holmund, JT; Hornung, R; Janik, JE; Kopp, WC; Longo, DL; Sznol, M; Urba, WJ; Wiltrout, RH | 1 |
| Burke, M; Denekamp, J; Farmer, K; Hill, S; O'Reilly, SM; Rustin, GJ | 1 |
| Chu, E; Feldmann, M; Haworth, C; O'Reilly, SM; Rustin, GJ | 1 |
| Dennis, MF; Howells, N; O'Reilly, SM; Rustin, GJ; Stratford, MR; Watfa, RR | 1 |
| Watts, ME; Woodcock, M | 1 |
| Baguley, BC; O'Reilly, SM; Rustin, GJ; Thomsen, LL | 1 |
| Bleehen, NM; Dennis, I; Honess, DJ; Maughan, TS; Ward, R; Workman, P | 1 |
| Clauss, M; Denekamp, J; Murray, JC; Stern, D | 1 |
| Ghosh, AK; Mellor, M; Prendiville, J; Thatcher, N | 1 |
| Carrington, B; Craig, RP; Dazzi, H; Ghosh, A; Johnson, RJ; Loriaux, EM; Mellor, M; Thatcher, N | 1 |
| Clavel, M; Dodion, P; Gundersen, S; Kaye, SB; Monfardini, S; Renard, J; Smith, J; Stoter, G; ten Bokkel-Huinink, W; Wagener, DT | 1 |
| Bleehen, NM; Kaye, SB; Kerr, DJ; Lewis, C; Maughan, T; Newlands, E; Rustin, G | 1 |
4 trial(s) available for flavone acetic acid and Malignant Melanoma
| Article | Year |
|---|---|
A phase I clinical trial of flavone-8-acetic acid in combination with interleukin 2.
Topics: Antineoplastic Agents; Carcinoma; Drug Administration Schedule; Female; Flavonoids; Humans; Interleukin-2; Male; Melanoma; Neoplasms; Treatment Outcome | 1995 |
Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma: I. Clinical and vascular studies.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Blood Coagulation; Blood Pressure; Brain Neoplasms; Drug Administration Schedule; Female; Flavonoids; Humans; Hypotension; Interleukin-2; Male; Melanoma; Middle Aged; Recombinant Proteins | 1993 |
Flavone acetic acid (FAA) with recombinant interleukin-2 (TIL-2) in advanced malignant melanoma. II: Induction of nitric oxide production.
Topics: Antineoplastic Combined Chemotherapy Protocols; Flavonoids; Humans; Interleukin-2; Melanoma; Nitric Oxide; Recombinant Proteins; Time Factors | 1992 |
Tumour concentrations of flavone acetic acid (FAA) in human melanoma: comparison with mouse data.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Drug Evaluation; Female; Flavonoids; Humans; Male; Mammary Neoplasms, Animal; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Middle Aged; Neoplasm Transplantation; Sarcoma | 1992 |
8 other study(ies) available for flavone acetic acid and Malignant Melanoma
| Article | Year |
|---|---|
Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma. III: Cytokine studies.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytokines; Female; Flavonoids; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-1; Interleukin-2; Interleukin-6; Male; Melanoma; Middle Aged; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1993 |
Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma. IV: Pharmacokinetics and toxicity of flavone acetic acid and its metabolites.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Flavonoids; Glucuronates; Humans; Infusions, Intravenous; Interleukin-2; Melanoma; Recombinant Proteins | 1993 |
Flavone acetic acid induced changes in human endothelial permeability: potentiation by tumour-conditioned medium.
Topics: Antineoplastic Agents; Cell Membrane Permeability; Cell Survival; Culture Media; Cytoskeleton; Endothelium, Vascular; Flavonoids; Humans; In Vitro Techniques; Melanoma; Tumor Cells, Cultured | 1992 |
Selective induction of endothelial cell tissue factor in the presence of a tumour-derived mediator: a potential mechanism of flavone acetic acid action in tumour vasculature.
Topics: Blood Coagulation Factors; Culture Media; Endothelium, Vascular; Flavonoids; Humans; Melanoma; Molecular Weight; Thromboplastin; Tumor Cells, Cultured | 1991 |
Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: immunological studies.
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Cytotoxicity, Immunologic; Drug Evaluation; Female; Flavonoids; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Male; Melanoma; Recombinant Proteins | 1990 |
Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: a phase II study.
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Flavonoids; Humans; Interleukin-2; Male; Melanoma; Middle Aged; Recombinant Proteins | 1990 |
Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanoma.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Flavonoids; Head and Neck Neoplasms; Humans; Melanoma; Middle Aged | 1990 |
Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Drug Evaluation; Female; Flavonoids; Humans; Male; Melanoma; Middle Aged | 1989 |